Entities / Company
Innoviva (United States).
company in Burlingame, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 15
What's happening
Gone quiet
No new reports in 90+ days-
Trump pledged to unleash American oil and gas production, involving the company Innoviva.Some support1 report
-
Christine Coyne was appointed CCO at Iterum Therapeutics, which is launching ORLYNVAH™ in the US.Some support2 reports
-
Innoviva (United States) is working to make quantum computing a reality.Speculative1 report
-
Innoviva (United States) reported strong earnings on August 9, 2025, beating market expectations.Some support2 reports
-
Innoviva's subsidiary is recognized for its products ZEVTERA and XACDURO, which treat serious infections.Some support1 report
-
Innoviva was identified as the largest shareholder of Armata Pharmaceuticals in August 2025.Some support1 report
-
Innoviva received royalties from GSK sales and acquired assets from Entasis Therapeutics.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Innoviva (United States) this week
News at the entities that move Innoviva (United States) most-
GSK StructuralUncertainty over a dispute involving GSK and AnaptysBio weighed on market sentiment.Moves Innoviva (United States)
-
Food and Drug Administration Shared contextKymera Therapeutics is seeking alignment from the FDA for its Phase III clinical trials.Moves Innoviva (United States)
Connections
The 2 strongest of 15, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
GSK Structural
Innoviva receives ongoing royalties from GSK sales, establishing a financial dependency.
-
Food and Drug Administration Shared context
Innoviva operates within the regulatory context overseen by the Food and Drug Administration.
History
Events by the month they beganJune 2026
7 events- Trump pledged to unleash American oil and gas production, involving the company Innoviva.
- Christine Coyne was appointed CCO at Iterum Therapeutics, which is launching ORLYNVAH™ in the US.
- Innoviva (United States) is working to make quantum computing a reality.
- Innoviva (United States) reported strong earnings on August 9, 2025, beating market expectations.
- Innoviva's subsidiary is recognized for its products ZEVTERA and XACDURO, which treat serious infections.
- Innoviva was identified as the largest shareholder of Armata Pharmaceuticals in August 2025.
- Innoviva received royalties from GSK sales and acquired assets from Entasis Therapeutics.